American Pharmacogenomics Association
行业协会
San Luis Obispo，California 1,374 位关注者
(APGxA) is dedicated to advancing the scientific understanding and application of pharmacogenomics.
关于我们
(APGxA) is a professional organization dedicated to advancing the scientific understanding and application of pharmacogenomics, a field that studies how an individual’s genetic makeup influences their response to medications. The American Pharmacogenomics Association also referred to as APGxA, plays a crucial role in the field of pharmacogenomics, which examines the impact of genetic makeup on drug response. As a central hub for professionals in this area, APGxA drives education, research, and collaboration, organizing events and publishing work to integrate pharmacogenomics into clinical practice. APGxA is pivotal in connecting genomic science with everyday healthcare, striving to improve patient care through personalized, effective, and safer drug therapies tailored to individual genetic profiles.
- 网站
-
https://americanpharmacogenomicsassociation.com
American Pharmacogenomics Association的外部链接
- 所属行业
- 行业协会
- 规模
- 2-10 人
- 总部
- San Luis Obispo，California
- 类型
- 教育机构
- 创立
- 2023
- 领域
- pharmacogenomics、pharmacogenetics、pgx和personalized medicine
地点
-
主要
获取路线
US，California，San Luis Obispo
American Pharmacogenomics Association员工
-
Patricia A. Camazzola, PharmD??
Precision Medicine Pharmacist / Board Member, American Pharmacogenomics Association / Digital Writer / Advocate for the advancement of…
-
Mostafa Kohif
Pharmapreneur | Driving Innovation in Precision Medicine & PharmacoGenomics
-
Celeste Miranda
President @ American Pharmacogenomics Association (expanded to include Multi-Omics & Biomedical Informatics)
-
Destiny Eloghosa Ale
Founder, PharmaGenoXfE = PGx Advocacy || Doctor of Pharmacy in view || Executive Project Assistant, APGxA || Researcher || SDGs Campus Ambassador ||…
动态
-
Pharmacogenomics: Revolutionizing Elderly Care As healthcare professionals, we're witnessing a paradigm shift in geriatric care. Pharmacogenomics is paving the way for personalized medicine, especially for our aging population. Key insights: ? 16.8% of U.S. patients are exposed to multiple drugs with available pharmacogenomic guidelines ? 11.3% median reduction in annual healthcare costs for elderly patients on multiple medications ? 17% improvement in outcomes for antidepressants and antipsychotics with genetic testing The future of geriatric care lies in understanding and leveraging genetic factors to optimize drug therapy. As we move towards a healthcare system centered on personalized medicine, it's crucial for all professionals to stay informed about these advancements. Learn more about how pharmacogenomics is transforming elderly care: https://lnkd.in/gP65jmHr #Pharmacogenomics #GeriatricCare #PersonalizedMedicine #HealthcareInnovation #apgxa #pgx #pharmacogenomics
Pharmacogenomics and Aging: Personalized Medicine for the Golden Years
https://americanpharmacogenomicsassociation.com
-
The future of healthcare is here, and it's personalized. Pharmacogenomics is revolutionizing the biotech industry, offering tailored treatments based on an individual's unique genetic profile. Key insights from our latest research: ? The pharmacogenomics market is projected to reach $40.6 billion by 2033 ? AI and big data analytics are accelerating progress ? Recent conferences highlight growing optimism in the sector ? The industry is overcoming challenges in regulation, integration, and cost As professionals in the biotech and healthcare sectors, it's crucial to understand the impact of pharmacogenomics on patient care and drug development. Are you prepared for this shift towards personalized medicine? Read our in-depth analysis and explore the opportunities in this rapidly evolving field: https://lnkd.in/gATiy5_a #Pharmacogenomics #Biotech #PersonalizedMedicine #HealthcareInnovation #apgxa #pharmacogenomics #pgx
Exploring the Business of Pharmacogenomics: The Next Big Wave in Biotech?
https://americanpharmacogenomicsassociation.com